NAD+observational2009

Application of a coupled enzyme assay to characterize nicotinamide riboside kinases.

Analytical biochemistry

confidence

Key findings

Describes a coupled enzyme assay to characterize Nrk kinetic properties; no clinical or biological endpoints reported.

View source on PubMed (PMID 19027704) ↗

Sample size
Not reported
Population
In vitro enzyme assay (human Nrk isoforms)
Dosing
Not reported
Duration
Not reported
Route
Not applicable
Blinding
not_reported
Controls
none
Drug class
coenzyme
Full abstract

The recently identified nicotinamide riboside kinases (Nrks) constitute a distinct pathway of nicotinamide adenine dinucleotide (NAD) biosynthesis. Here we present the combination of an established optical adenosine triphosphatase (ATPase) test, the pyruvate kinase/lactate dehydrogenase system, with the Nrk-catalyzed reaction to determine kinetic properties of these enzymes, in particular affinities for ATP. The assay allows variation of both nucleoside and phosphate donor substrates, thereby providing major advantages for the characterization of these enzymes. We confirm previously established kinetic parameters and identify differences in substrate selectivity between the two human Nrk isoforms. The proposed assay is inexpensive and may be applied for high-throughput screening.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.